| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
908 Devices Inc (NASDAQ: MASS)
MASS Technical Analysis
1.5
| As on 1st Aug 2025 MASS STOCK Price closed @ 6.42 and we RECOMMEND Buy for LONG-TERM with Stoploss of 4.74 & Sell for SHORT-TERM with Stoploss of 6.69 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MASSSTOCK Price
| Open | 6.37 | Change | Price | % |
| High | 6.64 | 1 Day | -0.13 | -1.98 |
| Low | 6.37 | 1 Week | -0.91 | -12.41 |
| Close | 6.42 | 1 Month | -1.55 | -19.45 |
| Volume | 287651 | 1 Year | -1.25 | -16.30 |
| 52 Week High 7.97 | 52 Week Low 1.84 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| NVDA | 173.72 | -2.33% |
| OPEN | 2.10 | 14.13% |
| EQ | 0.71 | 82.05% |
| AMZN | 214.75 | -8.27% |
| NCNA | 0.04 | 0.00% |
| LMDX | 0.02 | 0.00% |
| BTAI | 1.37 | 4.58% |
| AKTS | 0.04 | 0.00% |
| AAPL | 202.38 | -2.50% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| MASS Daily Charts |
MASS Intraday Charts |
Whats New @ Bazaartrend |
MASS Free Analysis |
|
|
MASS Important Levels Intraday
| RESISTANCE | 6.94 |
| RESISTANCE | 6.77 |
| RESISTANCE | 6.67 |
| RESISTANCE | 6.57 |
| SUPPORT | 6.27 |
| SUPPORT | 6.17 |
| SUPPORT | 6.07 |
| SUPPORT | 5.90 |
MASS Forecast August 2025
| 4th UP Forecast | 9.29 |
| 3rd UP Forecast | 8.37 |
| 2nd UP Forecast | 7.8 |
| 1st UP Forecast | 7.23 |
| 1st DOWN Forecast | 5.61 |
| 2nd DOWN Forecast | 5.04 |
| 3rd DOWN Forecast | 4.47 |
| 4th DOWN Forecast | 3.55 |
MASS Weekly Forecast
| 4th UP Forecast | 8.15 |
| 3rd UP Forecast | 7.60 |
| 2nd UP Forecast | 7.25 |
| 1st UP Forecast | 6.91 |
| 1st DOWN Forecast | 5.93 |
| 2nd DOWN Forecast | 5.59 |
| 3rd DOWN Forecast | 5.24 |
| 4th DOWN Forecast | 4.69 |
MASS Forecast2025
| 4th UP Forecast | 18.43 |
| 3rd UP Forecast | 14.58 |
| 2nd UP Forecast | 12.2 |
| 1st UP Forecast | 9.82 |
| 1st DOWN Forecast | 3.02 |
| 2nd DOWN Forecast | 0.64 |
| 3rd DOWN Forecast | -1.74 |
| 4th DOWN Forecast | -5.59 |
908 Devices Inc ( NASDAQ USA Symbol : MASS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MASS Business Profile
908 Devices Inc. develops and sells measurement devices for chemical and biochemical analysis in North America, Europe, the Middle East, Africa, and the Asia Pacific. It offers handheld and desktop mass spectrometry (Mass Spec) devices for the point-of-need applications in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts. Address: 645 Summer Street, Boston, MA, United States, 02210
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service